Sensei Biotherapeutics In... (SNSE)
NASDAQ: SNSE
· Real-Time Price · USD
7.20
0.65 (9.92%)
At close: Jun 18, 2025, 12:22 PM
9.92% (1D)
| Bid | 6.97 |
| Market Cap | 181.5M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -29.03M |
| EPS (ttm) | -1.15 |
| PE Ratio (ttm) | -6.26 |
| Forward PE | -0.43 |
| Analyst | Buy |
| Ask | 7.15 |
| Volume | 25,847 |
| Avg. Volume (20D) | 137,155 |
| Open | 6.43 |
| Previous Close | 6.55 |
| Day's Range | 6.18 - 7.25 |
| 52-Week Range | 5.00 - 17.40 |
| Beta | 0.10 |
About SNSE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SNSE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SNSE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 days ago
-10.58%
Sensei Biotherapeutics shares are trading lower af...
Unlock content with
Pro Subscription
2 months ago
+17.98%
Sensei Biotherapeutics shares are trading higher after the company released its preliminary dose expansion data for Solnerstotug in PD-(L)1 resistant tumors.
